논문KCI 등재
Macrophage ATG16L1: Potential candidate for metabolic dysfunction-associated steatohepatitis treatment: Editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (19)
- Llovet JM, "Hepatocellular carcinoma", Nat Rev Dis Primers, 7, pp.6~ (2021)
- Llovet JM, "Nonalcoholic steatohepatitisrelated hepatocellular carcinoma : pathogenesis and treatment", Nat Rev Gastroenterol Hepatol, 20, pp.487~503 (2023)
- Wong VW, "Changing epidemiology, global trends and implications for outcomes of NAFLD", J Hepatol, 79, pp.842~852 (2023)
- Kingwell K, "NASH field celebrates ‘hurrah moment’ with a first FDA drug approval for the liver disease", Nat Rev Drug Discov, 23, pp.235~237 (2024)
- Loomba R, "Mechanisms and disease consequences of nonalcoholic fatty liver disease", Cell, 184, pp.2537~2564 (2021)
- Sheka AC, "Nonalcoholic steatohepatitis : A review", JAMA, 323, pp.1175~1183 (2020)
- Chen Z, "Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease", Free Radic Biol Med, 152, pp.116~141 (2020)
- Kazankov K, "The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", Nat Rev Gastroenterol Hepatol, 16, pp.145~159 (2019)
- Zhu C, "Maladaptive regeneration-the reawakening of developmental pathways in NASH and fibrosis", Nat Rev Gastroenterol Hepatol, 18, pp.131~142 (2021)
- Tsuchida T, "Mechanisms of hepatic stellate cell activation", Nat Rev Gastroenterol Hepatol, 14, pp.397~411 (2017)
- Yu J, "Hepatocyte TLR4 triggers inter-hepatocyte Jagged1", Notch signaling to determine NASH-induced fibrosis, 2021, pp.13, eabe1692~
- Parzych KR, "An overview of autophagy : morphology, mechanism, and regulation", Antioxid Redox Signal, 20, pp.460~473 (2014)
- Madrigal-Matute J, "Regulation of liver metabolism by autophagy", Gastroenterology, 150, pp.328~339 (2016)
- Yamamoto H, "Autophagy genes in biology and disease", Nat Rev Genet, 24, pp.382~400 (2023)
- Gual P, "Autophagy in chronic liver diseases : the two faces of Janus", Am J Physiol Cell Physiol, 312, pp.C263~C273 (2017)
- Lodder J, "Macrophage autophagy protects against liver fibrosis in mice", Autophagy, 11, pp.1280~1292 (2015)
- Singh R, "Autophagy regulates lipid metabolism", Nature, 458, pp.1131~1135 (2009)
- Hernández-Gea V, "Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues", Gastroenterology, 142, pp.938~946 (2012)
- Wang Q, "Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy", Clin Mol Hepatol, 30, pp.515~538 (2024)
관련 논문AI추천
Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”Haoming Zhou, Ling Lu, Qingfa Bu, Qi Wang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagyHaoming Zhou, Jinren Zhou, Ling Lu, Qingfa Bu, Qi Wang, Yuan Liang, Yufeng Pan, Zibo Xu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제3호TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”Andrea Caddeo, Rosellina M. Mancina대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”Baokai Sun, Likun Zhuang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호A complement to epigenetics in metabolic dysfunctionassociated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunctionassociated steatotic liver disease”Glenn S. Gerhard, Johanna K. DiStefano대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Stabilizing hepatic fatty acid oxidation: Editorial on “USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination”Ja Hyun Koo, Myeung Gi Choi, Na Young Lee대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (78건)
Congratulatory remarks김원pp. 2-2Preface김승업pp. 3-3PrefaceDae Won Junpp. 4-4Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysisYoung Eun Chon, Han Ah Lee, Hee Yeon Kim, Young-Joo Jin, Jung Hwan Yu, Ji Won Han, Mi Na Kim, Jihyun An, Seung Up Kim, Miyoung Choi, Dae Won Junpp. 117-133Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysisYoung Eun Chon, Miyoung Choi, Ji Won Han, 전대원, Mi Na Kim, Jung Hwan Yu, Young-Joo Jin, Hee Yeon Kim, Han Ah Lee, 김승업, Jihyun An, Gunho Kimpp. 134-146
